Trials / NCT06846151
Retinal Investigation Using Optos OCT Device
Not yet recruiting N/A Device
- Sponsor
- Optos, PLC
- Treatment
- retinal functional imaging
- Gene
- Not stated
- Conditions
- AMD - Age-Related Macular Degeneration, Retinitis Pigmentosa (RP), Diabetic Retinopathy, Control Patients
- Ages
- 18 Years to no upper limit
- Enrollment
- 120 participants
- Started
- 2025-05
- Main results expected
- 2025-11
- Results posted
- Not yet
- Record last updated
- 2025-02-25
What the study is testing
Retinal investigation using OCT with control and diseased eyes
Where it runs
No sites listed yet.